Intellectual Property India Publishes Patent Application for 'Conditionally Active Anti-Epcam Antibodies, Antibody Fragments And Constructs Incorporating Same' Filed by Bioatla, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517092440 A) filed by Bioatla, Inc., San Diego, on Sept. 26, for 'conditionally active anti-epcam antibodies, antibody fragments and constructs incorporating same.'

Inventor(s) include Short, Jay M.; Frey, Gerhard; and Chang, Hwai Wen.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "A conditionally active bispecific antibody comprising an IgG antibody or antibody fragment that binds to a human EpCAM protein comprising a light chain variable region having three complementarity determining regions L1, L2 and L3; a heavy chain variable region having three complementarity determining regions H1, H2 and H3; and at least one scFv antibody fragment that binds to a T-lymphocyte protein linked to a C-terminus of at least one light chain of the IgG antibody or antibody fragment."

The patent application was internationally filed on Mar. 01, 2024, under International application No.PCT/US2024/017940.

Disclaimer: Curated by HT Syndication.